Cargando…

Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in China. Sinisan (SNS) is a traditional Chinese medicine formula that has been widely used in treating chronic liver diseases, including NAFLD. However, its underlying biological mechanisms are still unclear. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xiaoyi, Hou, Weixin, Liang, Jiajun, Fang, Peng, Dou, Bo, Wang, Zisong, Sai, Jiayang, Xu, Tian, Ma, Chongyang, Zhang, Qiuyun, Cheng, Fafeng, Wang, Xueqian, Wang, Qingguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430321/ https://www.ncbi.nlm.nih.gov/pubmed/34512330 http://dx.doi.org/10.3389/fphar.2021.693701

Ejemplares similares

Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study
por: Cheng, Fafeng, et al.
Publicado: (2017)

An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
por: Ma, Chongyang, et al.
Publicado: (2020)

The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis
por: Ma, Chongyang, et al.
Publicado: (2021)

Network Pharmacology-Based Approach to Revealing Biological Mechanisms of Qingkailing Injection against IschemicStroke: Focusing on Blood-Brain Barrier
por: Zhang, Shuang, et al.
Publicado: (2020)

A Systems Pharmacology-Based Study of the Molecular Mechanisms of San Cao Decoction for Treating Hypertension
por: Ma, Chongyang, et al.
Publicado: (2019)

Jieduan–Niwan Formula Ameliorates Oxidative Stress and Apoptosis in Acute-on-Chronic Liver Failure by Suppressing HMGB1/TLR-4/NF-κB Signaling Pathway: A Study In Vivo and In Vitro
por: Fang, Peng, et al.
Publicado: (2022)

Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease
por: Shao, Qi, et al.
Publicado: (2021)

Network pharmacology analysis reveals neuroprotective effects of the Qin-Zhi-Zhu-Dan Formula in Alzheimer’s disease
por: Xu, Wenxiu, et al.
Publicado: (2022)

Baicalin Attenuates Oxygen–Glucose Deprivation/Reoxygenation–Induced Injury by Modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 Signaling Axes in Neuron–Astrocyte Cocultures
por: Li, Changxiang, et al.
Publicado: (2021)

Network Pharmacology Approach to Explore the Potential Mechanisms of Jieduan-Niwan Formula Treating Acute-on-Chronic Liver Failure
por: Liang, Jiajun, et al.
Publicado: (2020)

Quercetin Attenuates d-GaLN-Induced L02 Cell Damage by Suppressing Oxidative Stress and Mitochondrial Apoptosis via Inhibition of HMGB1
por: Fang, Peng, et al.
Publicado: (2020)

Top 100 cited articles on rheumatoid arthritis: A bibliometric analysis
por: Yin, Xiangjun, et al.
Publicado: (2019)

Erythropoietin Pathway: A Potential Target for the Treatment of Depression
por: Ma, Chongyang, et al.
Publicado: (2016)

Toxicological safety evaluation of Qin-Zhi-Zhu-Dan formula in rats during the treatment and recovery periods
por: Xu, Wenxiu, et al.
Publicado: (2022)

Quercetin Reduces Oxidative Stress and Apoptosis by Inhibiting HMGB1 and Its Translocation, Thereby Alleviating Liver Injury in ACLF Rats
por: Fang, Peng, et al.
Publicado: (2021)

Systems Pharmacology Based Study of the Molecular Mechanism of SiNiSan Formula for Application in Nervous and Mental Diseases
por: Shen, Xia, et al.
Publicado: (2016)

Potential mechanisms underlying the therapeutic roles of sinisan formula in depression: Based on network pharmacology and molecular docking study
por: Wang, Hui, et al.
Publicado: (2022)

HMGB1-Induced Hepatocyte Pyroptosis Expanding Inflammatory Responses Contributes to the Pathogenesis of Acute-on-Chronic Liver Failure (ACLF)
por: Hou, Weixin, et al.
Publicado: (2021)

Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs
por: Liang, Jiajun, et al.
Publicado: (2022)

Corrigendum to “Systematic Understanding of the Mechanism of Baicalin against Ischemic Stroke through a Network Pharmacology Approach”
por: Xu, Tian, et al.
Publicado: (2019)

Network Pharmacology and Bioinformatics Approach Reveals the Therapeutic Mechanism of Action of Baicalein in Hepatocellular Carcinoma
por: Ma, Chongyang, et al.
Publicado: (2019)

Integrated Analysis of the Mechanisms of Da-Chai-Hu Decoction in Type 2 Diabetes Mellitus by a Network Pharmacology Approach
por: Ren, Beida, et al.
Publicado: (2020)

Chinese Medicine Injection Qingkailing for Treatment of Acute Ischemia Stroke: A Systematic Review of Randomized Controlled Trials
por: Cheng, Fafeng, et al.
Publicado: (2012)

Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury
por: Ma, Chongyang, et al.
Publicado: (2021)

The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology
por: Jing, Haoran, et al.
Publicado: (2021)

A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
por: Rieger, Theodore R., et al.
Publicado: (2022)

Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway
por: Ma, Chongyang, et al.
Publicado: (2019)

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
por: Yang, Mengying, et al.
Publicado: (2020)

Systematic Understanding of the Mechanism of Baicalin against Ischemic Stroke through a Network Pharmacology Approach
por: Xu, Tian, et al.
Publicado: (2018)

Integrating Network Pharmacology and RT-qPCR Analysis to Investigate the Mechanisms Underlying ZeXie Decoction-Mediated Treatment of Non-alcoholic Fatty Liver Disease
por: Wu, Jiashuo, et al.
Publicado: (2021)

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
por: Li, Yunjia, et al.
Publicado: (2022)

Synergistic neuroprotective effects of Geniposide and ursodeoxycholic acid in hypoxia-reoxygenation injury in SH-SY5Y cells
por: Cheng, Fafeng, et al.
Publicado: (2018)

Cholic Acid Protects In Vitro Neurovascular Units against Oxygen and Glucose Deprivation-Induced Injury through the BDNF-TrkB Signaling Pathway
por: Li, Changxiang, et al.
Publicado: (2020)

Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle
por: Liang, Jiajun, et al.
Publicado: (2023)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)

Refined Qingkailing Protects MCAO Mice from Endoplasmic Reticulum Stress-Induced Apoptosis with a Broad Time Window
por: Cheng, Fafeng, et al.
Publicado: (2012)

RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
por: Zhou, Wanwan, et al.
Publicado: (2021)

Baicalin's Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative Effects In Vitro and In Vivo
por: Cheng, Fafeng, et al.
Publicado: (2013)

Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
por: Xu, Jingqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibg4vjhtvitecbc8qd3r6s0bcu